Evidence map›Paper›PMID 36372623›Full record

Observational studyJournal of science and medicine in sport2023

Low prevalence of cardiac abnormalities in competitive athletes at return-to-play after COVID-19.

Viviana Maestrini, Marco Penza, Domenico Filomena, Lucia Ilaria Birtolo, Sara Monosilio, Erika Lemme, Maria Rosaria Squeo, Ruggiero Mango, Giuseppe Di Gioia, Andrea Serdoz and 4 more

Open access · greenAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Journal of science and medicine in sport, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Viviana MaestriniInstitute of Sport Medicine, Sport and Health, National Italian Olympic Committee, Italy; Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Italy. Electronic address: viviana.maestrini@uniroma1.it.
Marco PenzaInstitute of Sport Medicine, Sport and Health, National Italian Olympic Committee, Italy; Department of Medical Biotechnology and Translational Medicine, University of Milan, Italy.
Domenico FilomenaInstitute of Sport Medicine, Sport and Health, National Italian Olympic Committee, Italy; Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Italy.
Lucia Ilaria BirtoloInstitute of Sport Medicine, Sport and Health, National Italian Olympic Committee, Italy; Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Italy.
Sara MonosilioInstitute of Sport Medicine, Sport and Health, National Italian Olympic Committee, Italy; Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Italy.
Erika LemmeInstitute of Sport Medicine, Sport and Health, National Italian Olympic Committee, Italy.
Maria Rosaria SqueoInstitute of Sport Medicine, Sport and Health, National Italian Olympic Committee, Italy.
Ruggiero MangoInstitute of Sport Medicine, Sport and Health, National Italian Olympic Committee, Italy.
Giuseppe Di GioiaInstitute of Sport Medicine, Sport and Health, National Italian Olympic Committee, Italy.
Andrea SerdozInstitute of Sport Medicine, Sport and Health, National Italian Olympic Committee, Italy.
Roberto FioreInstitute of Sport Medicine, Sport and Health, National Italian Olympic Committee, Italy.
Francesco FedeleInstitute of Sport Medicine, Sport and Health, National Italian Olympic Committee, Italy; Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Italy.
Antonio PellicciaInstitute of Sport Medicine, Sport and Health, National Italian Olympic Committee, Italy.
Barbara Di GiacintoInstitute of Sport Medicine, Sport and Health, National Italian Olympic Committee, Italy.
Federazione Medico Sportiva Italiana · ITSapienza University of Rome · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveto evaluate the prevalence of cardiac involvement after COVID-19 in competitive athletes at return-to-play (RTP) evaluation, following the recommended Italian protocol including cardiopulmonary exercise test (CPET) and 24-Hour Holter monitoring. DESIGN AND

methodsthis is a single centre observational, cross-sectional study. Since October 2020, all competitive athletes (age ≥ 14 years) evaluated in our Institute after COVID-19, prior RTP were enrolled. The protocol dictated by the Italian governing bodies included: 12‑lead ECG, blood test, CPET, 24-h ECG monitoring, spirometry. Cardiovascular Magnetic Resonance (CMR) was performed based on clinical indication.

results219 consecutive athletes were examined (59% male), age 23 years (IQR 19-27), 21% asymptomatic, 77% mildly symptomatic, 2% with previous pneumonia. The evaluation was performed after a median of 10 (6-17) days from negative SARS-CoV-2 swab. All athletes showed a good exercise capacity at CPET without cardiovascular and respiratory limitations. Uncommon premature ventricular contractions (PVCs) were found in 9.5% (n = 21) at CPET/Holter ECG monitoring. Two athletes (0.9%) were diagnosed with acute myocarditis (by CMR) and another one with new pericardial effusion. All the three athletes were temporally restricted from sport participation.

conclusionsMyocarditis in competitive athletes screened after COVID-19 resolution was detected in a low minority of the cases (0.9%). However, a non-negligible prevalence of uncommon PVCs (9%) was observed, either at CPET and/or Holter ECG monitoring, including all athletes with COVID-19 related cardiovascular abnormalities.

Indexed as

COVID-19MyocarditisAdolescentAdultAthletesCross-Sectional StudiesFemaleHumansMalePrevalenceReturn to SportSARS-CoV-2Young AdultAthletesCardiopulmonary exercise test (CPET)Cardiovascular evaluationCOVID-19Return-to-play (RTP)SARS-CoV-2

Identifiers

PMID36372623
PMCPMC9622018
OpenAlexW4307899373

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.